[银屑病全身用药或生物治疗的处方及治疗监测] - Suppr

Suppr

超能文献

[Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].

作者信息

Boulinguez S

机构信息

Service de Dermatologie, Hôpital La Grave, Place Lange, TSA 60033, 31059 Toulouse cedex, France.

出版信息

Ann Dermatol Venereol. 2010 Apr;137(4 Suppl):8-12. doi: 10.1016/S0151-9638(10)70011-9.

DOI:10.1016/S0151-9638(10)70011-9

PMID:20510169

Abstract

摘要

相似文献

[Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].

Ann Dermatol Venereol. 2010 Apr;137(4 Suppl):8-12. doi: 10.1016/S0151-9638(10)70011-9.

Developments in systemic immunomodulatory therapy for psoriasis.

Curr Opin Pharmacol. 2007 Aug;7(4):434-44. doi: 10.1016/j.coph.2007.06.002. Epub 2007 Jul 12.

Treatment of moderate-to-severe plaque psoriasis.

G Ital Dermatol Venereol. 2009 Dec;144(6):701-11.

Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.

Rheumatology (Oxford). 2009 Nov;48(11):1464; author reply 1465. doi: 10.1093/rheumatology/kep238. Epub 2009 Aug 11.

Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.

JAMA Dermatol. 2017 Nov 1;153(11):1147-1157. doi: 10.1001/jamadermatol.2017.3029.

Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.

Rheumatology (Oxford). 2009 May;48(5):569-72. doi: 10.1093/rheumatology/kep023. Epub 2009 Mar 9.

Combination therapy of cyclosporine and anti-tumor necrosis factor α in psoriasis: a case series of 10 patients.

Dermatol Ther. 2015 May-Jun;28(3):126-30. doi: 10.1111/dth.12196. Epub 2015 Jan 30.

Treatment of psoriasis. Part 2. Systemic therapies.

J Am Acad Dermatol. 2001 Nov;45(5):649-61; quiz 662-4. doi: 10.1067/mjd.2001.117047.

Methotrexate and other chemotherapeutic agents used to treat psoriasis.

Dermatol Clin. 1995 Oct;13(4):875-90.

Position statement: immunomodulator therapy for inflammatory Bowel disease.

Isr Med Assoc J. 2003 Mar;5(3):164-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].

作者信息

Boulinguez S

机构信息

Service de Dermatologie, Hôpital La Grave, Place Lange, TSA 60033, 31059 Toulouse cedex, France.

出版信息

Ann Dermatol Venereol. 2010 Apr;137(4 Suppl):8-12. doi: 10.1016/S0151-9638(10)70011-9.

DOI:10.1016/S0151-9638(10)70011-9

PMID:20510169

Abstract

摘要

相似文献

[Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].

Ann Dermatol Venereol. 2010 Apr;137(4 Suppl):8-12. doi: 10.1016/S0151-9638(10)70011-9.

Developments in systemic immunomodulatory therapy for psoriasis.

Curr Opin Pharmacol. 2007 Aug;7(4):434-44. doi: 10.1016/j.coph.2007.06.002. Epub 2007 Jul 12.

Treatment of moderate-to-severe plaque psoriasis.

G Ital Dermatol Venereol. 2009 Dec;144(6):701-11.

Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.

Rheumatology (Oxford). 2009 Nov;48(11):1464; author reply 1465. doi: 10.1093/rheumatology/kep238. Epub 2009 Aug 11.

Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.

JAMA Dermatol. 2017 Nov 1;153(11):1147-1157. doi: 10.1001/jamadermatol.2017.3029.

Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.

Rheumatology (Oxford). 2009 May;48(5):569-72. doi: 10.1093/rheumatology/kep023. Epub 2009 Mar 9.

Combination therapy of cyclosporine and anti-tumor necrosis factor α in psoriasis: a case series of 10 patients.

Dermatol Ther. 2015 May-Jun;28(3):126-30. doi: 10.1111/dth.12196. Epub 2015 Jan 30.

Treatment of psoriasis. Part 2. Systemic therapies.

J Am Acad Dermatol. 2001 Nov;45(5):649-61; quiz 662-4. doi: 10.1067/mjd.2001.117047.

Methotrexate and other chemotherapeutic agents used to treat psoriasis.

Dermatol Clin. 1995 Oct;13(4):875-90.

Position statement: immunomodulator therapy for inflammatory Bowel disease.

Isr Med Assoc J. 2003 Mar;5(3):164-9.